A Phase I Study of BR790 in Subjects With Advanced Solid Tumors
Clinical trial NCT04891653 · UNKNOWN
Trial details
- NCT number
- NCT04891653
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2023-06-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.